Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1983 1
1991 1
1993 1
1995 1
2003 1
2004 1
2008 2
2009 3
2010 2
2011 1
2012 5
2013 1
2015 2
2016 3
2017 1
2018 1
2019 1
2020 2
2021 1
2022 2
2023 3
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis.
Fox RJ, Bar-Or A, Traboulsee A, Oreja-Guevara C, Giovannoni G, Vermersch P, Syed S, Li Y, Vargas WS, Turner TJ, Wallstroem E, Reich DS; HERCULES Trial Group. Fox RJ, et al. N Engl J Med. 2025 May 15;392(19):1883-1892. doi: 10.1056/NEJMoa2415988. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202696 Clinical Trial.
Individual reserve in aging and neurological disease.
Holtzer R, Choi J, Motl RW, Foley FW, Picone MA, Lipton ML, Izzetoglu M, Hernandez M, Wagshul ME. Holtzer R, et al. Among authors: picone ma. J Neurol. 2023 Jun;270(6):3179-3191. doi: 10.1007/s00415-023-11656-8. Epub 2023 Mar 12. J Neurol. 2023. PMID: 36906731 Free PMC article.
The presence of SARS-CoV2 antibodies in MS patients.
Wallach AI, Picone MA. Wallach AI, et al. Among authors: picone ma. Mult Scler Relat Disord. 2021 May;50:102793. doi: 10.1016/j.msard.2021.102793. Epub 2021 Jan 23. Mult Scler Relat Disord. 2021. PMID: 33588315 Free PMC article.
Suicidal thinking in multiple sclerosis.
Gaskill A, Foley FW, Kolzet J, Picone MA. Gaskill A, et al. Among authors: picone ma. Disabil Rehabil. 2011;33(17-18):1528-36. doi: 10.3109/09638288.2010.533813. Epub 2010 Nov 22. Disabil Rehabil. 2011. PMID: 21091136
Life space assessment and falls in older adults with multiple sclerosis.
Holtzer R, Motl RW, Wagshul ME, Picone MA, Hernandez ME, Izzetoglu M, Lipton ML, Foley FW. Holtzer R, et al. Among authors: picone ma. Mult Scler Relat Disord. 2024 Jul;87:105671. doi: 10.1016/j.msard.2024.105671. Epub 2024 May 6. Mult Scler Relat Disord. 2024. PMID: 38728961 Free PMC article.
41 results